Heart Closure Devices Market Size, Share & Trends Analysis Report By Closure Type (CHD Closure, PFO Closure, LAA Closure), By Region (North America, APAC, Europe, LATAM, MEA)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global heart closure devices market size was exhibited at USD 2.85 billion in 2022 and is projected to hit around USD 10.67 billion by 2032, growing at a CAGR of 14.11% during the forecast period 2023 to 2032.

Key Pointers:

• North America dominated the global industry in 2022 and accounted for the largest share of more than 52.59% 
• The LAAC segment dominated the industry in 2022 and accounted for the largest share of 49.10% of the overall revenue.
• The Left Atrial Appendage Closure (LAAC) devices segment dominated the industry in 2022. Rising awareness campaigns in underserved markets, the growing prevalence of atrial fibrillation, and government initiatives drive the LAAC devise market
• Patent Foramen Ovale (PFO) market is significantly determined by the high occurrence of ischemic stroke. As per the Centers for Disease Control and Prevention (CDC), each year, more than 795,000 individuals in the U.S. have a stroke. About 87% of all strokes are ischemic strokes
• The development of Congenital Heart Defect (CHD) Closure devices is expected to be accelerated by the rising incidence of congenital heart disease. For instance, as per the CDC, CHDs affect approximately 1% of?or nearly 40,000?births per year in the U.S.
• Asia Pacific region is anticipated to register rapid growth in the coming years owing to the presence of high unmet needs coupled with a rapidly increasing geriatric population, availability of products at lower costs, and favorable government support
• Growing geographic expansion, country-specific approvals, and R&D investments by key companies, as well as the number of innovative product pipelines, are expected to contribute to market growth. In September 2022, Abbott announced that Amplatzer Talisman patent foramen ovale occlusion system has been approved by the U.S. FDA to cure patients with PFO at risk of recurrent stroke

Heart Closure Devices Market Report Scope

Heart defects closure devices are medical devices used for diagnosis and treatment of congenital heart defect, which include atrial septal defect, ventricular septal defect, left atrial appendage defect, and patent ductus arteriosus. These defects appear in the structure of the heart, which results in interference of normal flow of blood through the heart. Closure devices are employed to close an opening between right and left sides of the heart, thus treating congenital heart defects. 

Increase in incidence of congenital heart defects, upsurge in geriatric population, technological advancements in heart closure devices, and rise in adoption of MRI procedures are the key factors that drive the growth of the global heart defect closure devices market. However, high cost of production and stringent regulations associated with these devices restrain the market growth. On the contrary, increase in number of heart strokes and development of innovative products by key players are expected to provide remunerative opportunities for market expansion in the near future.

The utilization of 3D imaging and anatomical models in the manufacturing and planning processes of heart defect closure devices is gaining prominence in the market. This is expected to change the supply landscape of the industry, owing to characteristics such as personalization, adaptability, and flexibility provided by using 3D imaging technology. This in turn decreases the overall prostheses employed per patient along with the procedure time, which makes it a viable option in the production and planning process.

The global heart defects closure devices market is segmented into defect type, end user, and region. On the basis of defect type, the market is divided into atrial septal defect closure devices, left atrial appendage closure devices, patent foramen ovale closure devices, patent ductus arteriosus closure devices, and ventricular septal defect closure devices. By end user, it is classified into hospitals, and clinics. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the prominent players in the Heart Closure Devices Market include:

• Abbott
• W. L. Gore & Associates, Inc.
• Boston Scientific Corp.
• Occlutech
• Heartstitch
• SMT
• Cardia, Inc.
• Lifetech Scientific Corp.
• Lepu Medical Technology (Beijing)Co., Ltd.
• AtriCure Inc.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Heart Closure Devices market.

By Closure Type 

• Congenital Heart Defect Closure
  • By Technique
    • ASD
    • PDA (inclusive of PDA closure and embolization coils)
    • VSD
• PFO Closure
• LAA Closure

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)
• Frequently Asked Questions